Here are five things to know.
1. The board elected Brad Lerman as a new independent director, increasing the board size from eight to nine members.
2. Mr. Lerman has more than 25 years of experience in government relations and corporate strategy. He is senior vice president, general counsel and corporate secretary for Medtronic.
3. In his current role with Medtronic, Mr. Lerman leads the company’s global legal, government affairs, and ethics and compliance functions. He also has experience as executive vice president, general counsel and corporate secretary for Federal National Mortgage Association.
4. McKesson aims to regularly engage with shareholders on corporate governance and aims to include “the right mix of qualifications, perspectives and experiences” on the board of directors, according to Edward Mueller, the company’s lead independent director.
“The addition of Brad enhances our board’s overall skill set and supports the execution of McKesson’s strategy which is designed to deliver long-term growth and sustainable value creation for shareholders,” he said.
More articles on healthcare supply chain:
32+ supply chain companies for orthopedic & spine ASCs to know
The 2 reasons why Amazon tabled its plan to sell drugs to hospitals—and why ASCs might be a better bet
ASC supply chain tip of the day: track costs for better business management
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.